| Pharmaceutical active ingredients: |
| Lactobacillus Acidophilus |
| Available forms, composition and doses of Diarlac: |
| N / A |
| Diarlac medical category: |
| Human:Antidiabetic agentsAntidiarrhealsGIT regulators, antiflatulents and anti-inflammatories |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07FA01 - Lactic Acid producing organisms |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Urgo Laboratoires |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Diarfin Tablets | Attapulgite, activated; Nifuroxazide | Chile Laboratorios |
| Diargal | Food for Special Diets; Infant Feed | Gallia Laboratoires; Bonomelli Divisione Farmacia |
| Diarigoz | Infant Feed | Guigoz |
| Diaril | Glutaraldehyde; O-Phenylphenol; Phenol | MC Presidi Medico Chirurgici |
| Diarim | Nifuroxazide | Representaciones e Investigaciones Medicas |
| Diarlop Capsules | Loperamide Hydrochloride | Jagson Pal Pharmaceuticals |
| Diarlop Plus Capsules | Loperamide Hydrochloride | Jagson Pal Pharmaceuticals |
| Diarlop Plus Suspension | Metronidazole; Nalidixic Acid | Jagson Pal Pharmaceuticals |
| Diarlop Suspension | Nalidixic Acid | Jagson Pal Pharmaceuticals |
| Diarlop-CT | Ciprofloxacin; Tinidazole | Jagson Pal Pharmaceuticals |